Global Pharmaceuticals & Biotech Big Green Snowflakes

Abbott Laboratories (Pakistan)

Market Cap: PK₨115.3b

Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.

Biocon

Market Cap: ₹486.4b

Manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally.

Joinn Laboratories(China)Co.Ltd

Market Cap: CN¥22.2b

Provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally.

DreamCIS

Market Cap: ₩86.9b

Provides clinical research services in South Korea.

BioLineRx

Market Cap: ₪51.2m

A commercial stage biopharmaceutical company, develops and commercializes therapeutics for oncology and rare diseases.

Shanghai Shenqi Pharmaceutical Investment Management

Market Cap: CN¥3.4b

Operates as a pharmaceutical manufacturing holding investment company in China.

ChemoMetec

Market Cap: DKK 9.3b

Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.

Jiangsu Kanion PharmaceuticalLtd

Market Cap: CN¥9.5b

Researches and develops, produces, and sells Chinese medicines.

Chong Kun Dang Holdings

Market Cap: ₩233.3b

Manufactures and distributes pharmaceutical products in South Korea and internationally.

Daewoong Pharmaceutical

Market Cap: ₩1.6t

Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.

Shanghai Xiao Fang PharmaceuticalLtd

Market Cap: CN¥5.7b

Shanghai Xiao Fang Pharmaceutical Co., Ltd produces and sells medicines in China.

Vasundhara Rasayans

Market Cap: ₹557.5m

Engages in the manufacture and sale of antacids therapeutic category of active pharmaceutical ingredients (API) in India and internationally.

PYC Therapeutics

Market Cap: AU$720.3m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

Ishita Drugs and Industries

Market Cap: ₹225.0m

Manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally.

GenMont Biotech Incorporation

Market Cap: NT$1.7b

Engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan.

Cenra

Market Cap: NT$4.9b

Engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals.

Bal Pharma

Market Cap: ₹1.4b

Manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) in India and internationally.

Vitura Health

Market Cap: AU$44.4m

Engages in the sale and distribution of medicinal cannabis products in Australia.

Medicalsystem Biotechnology

Market Cap: CN¥4.1b

Engages in the research, development, production, and sales of in vitro diagnostic products in China.

Diaceutics

Market Cap: UK£120.1m

A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.

Artiva Biotherapeutics

Market Cap: US$88.2m

A clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers.

Kazia Therapeutics

Market Cap: US$8.7m

Operates as an oncology-focused biotechnology company in South Korea.

SciSparc

Market Cap: US$1.2m

A clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies.

Silo Pharma

Market Cap: US$5.8m

Silo Pharma Inc. operates as a developmental stage biopharmaceutical company.

Lyell Immunopharma

Market Cap: US$233.4m

A clinical-stage cell therapy company, develops chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors.

Upstream Bio

Market Cap: US$1.1b

A clinical-stage biotechnology company, develops treatments for inflammatory diseases focusing on severe respiratory disorders.

BioInvent International

Market Cap: SEK 1.9b

A clinical-stage company, discovers and develops immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally.

MBX Biosciences

Market Cap: US$388.0m

A clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.

Oryzon Genomics

Market Cap: €215.5m

A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS disorders.

SynAct Pharma

Market Cap: SEK 1.1b

A clinical stage biotechnology company, researches and develops medicines for the treatment of inflammatory diseases in Sweden.

Aligos Therapeutics

Market Cap: US$69.8m

A clinical-stage biopharmaceutical company, focuses on the development of novel therapeutics to address unmet medical needs in viral and liver diseases.

Knight Therapeutics

Market Cap: CA$641.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

VYNE Therapeutics

Market Cap: US$7.6m

A clinical-stage biopharmaceutical company, focuses on developing therapies to treat chronic inflammatory and immune-mediated conditions.

Bright Minds Biosciences

Market Cap: CA$432.4m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Assertio Holdings

Market Cap: US$76.8m

A pharmaceutical company, provides various products to patients in the United States.

ANI Pharmaceuticals

Market Cap: US$1.9b

A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.